ARS Pharmaceuticals Inc
NASDAQ:SPRY

Watchlist Manager
ARS Pharmaceuticals Inc Logo
ARS Pharmaceuticals Inc
NASDAQ:SPRY
Watchlist
Price: 10.66 USD 0.66% Market Closed
Market Cap: 1.1B USD

Intrinsic Value

The intrinsic value of one SPRY stock under the Base Case scenario is 17.88 USD. Compared to the current market price of 10.66 USD, ARS Pharmaceuticals Inc is Undervalued by 40%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

SPRY Intrinsic Value
17.88 USD
Undervaluation 40%
Intrinsic Value
Price
Base Case Scenario

Valuation History
ARS Pharmaceuticals Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about SPRY?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is SPRY valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for ARS Pharmaceuticals Inc.

Explain Valuation
Compare SPRY to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about SPRY?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
ARS Pharmaceuticals Inc

Current Assets 338.9m
Cash & Short-Term Investments 288.2m
Receivables 37.7m
Other Current Assets 13m
Non-Current Assets 33.9m
PP&E 2.6m
Intangibles 14.7m
Other Non-Current Assets 16.6m
Current Liabilities 50.9m
Accounts Payable 33m
Accrued Liabilities 17.3m
Other Current Liabilities 526k
Non-Current Liabilities 174.3m
Long-Term Debt 96.2m
Other Non-Current Liabilities 78m
Efficiency

Free Cash Flow Analysis
ARS Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
ARS Pharmaceuticals Inc

Revenue
142.8m USD
Cost of Revenue
-15.1m USD
Gross Profit
127.6m USD
Operating Expenses
-218.4m USD
Operating Income
-90.8m USD
Other Expenses
10.7m USD
Net Income
-80m USD
Fundamental Scores

SPRY Profitability Score
Profitability Due Diligence

ARS Pharmaceuticals Inc's profitability score is 17/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Sustainable 3Y Average Gross Margin
Negative 3Y Average Net Margin
Declining ROE
17/100
Profitability
Score

ARS Pharmaceuticals Inc's profitability score is 17/100. The higher the profitability score, the more profitable the company is.

SPRY Solvency Score
Solvency Due Diligence

ARS Pharmaceuticals Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Low D/E
Long-Term Solvency
61/100
Solvency
Score

ARS Pharmaceuticals Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SPRY Price Targets Summary
ARS Pharmaceuticals Inc

Wall Street analysts forecast SPRY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SPRY is 28.39 USD with a low forecast of 12.12 USD and a high forecast of 36.75 USD.

Lowest
Price Target
12.12 USD
14% Upside
Average
Price Target
28.39 USD
166% Upside
Highest
Price Target
36.75 USD
245% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

ARS Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for SPRY is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

SPRY Insider Trading
Buy and sell transactions by insiders

SPRY News

Other Videos
What is the Intrinsic Value of one SPRY stock?

The intrinsic value of one SPRY stock under the Base Case scenario is 17.88 USD.

Is SPRY stock undervalued or overvalued?

Compared to the current market price of 10.66 USD, ARS Pharmaceuticals Inc is Undervalued by 40%.

Back to Top